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Acetylsalicylic acid (AAS) is a drug utilized as analgesic, anti-inflammatory, and antipyretic medication, 
available worldwide and commonly used in Brazil. Salicylic acid (AS) is a precursor in AAS synthesis 
and is also produced during its degradation. The official United States Pharmacopoeia (USP) suggests 
the determination of these drugs by high performance liquid chromatography (HPLC), with ultraviolet 
detection, but this method has neither a high sensitivity (S
AAS
=0.12 mAbs/(µg/mL) and S
AS
=0.48 mAbs/
(µg/mL)) nor resolution (Rs=1.61). The purpose of this study was to develop a new more adequate, 
accurate method by liquid phase chromatography than the current official methodology, and to use this 
new method in the determination of the tenors of acetylsalicylic, as of salicylic acids in tablets. The 
parameters of the chromatographic system for both the AAS and AS were satisfactory. Selectivity was 
verified by absorption spectra comparison in the ultraviolet (UV) range, during and after substance 
retention time. The linear range for AAS was 0.21 to 0.39 mg/mL, and that for AS was 6.3 to 11.7 µg/mL.  
The correlation coefficients (r) of the analytical curves of AAS and AS were 0.9995 and 0.9988, 
respectively; and the detection and quantification limits for the AS were 0.23 and 0.69 µg/mL. The 
sensitivity (S
AAS
=1.88 mAbs/(µg/mL) and S
AS
=1.84 mAbs/(µg/mL)) and the resolution (Rs =5.06) show 
the improvement obtained using this method over that described by the USP.
Uniterms: High performance liquid chromatography. Acetylsalicylic acid/determination in tablets. 
Salicylic acid/determination in tablets. Tablets/quantitative analysis.
O ácido acetilsalicílico (AAS) é um fármaco utilizado como analgésico, antiinflamatório, antipirético, 
sendo amplamente comercializado e consumido no Brasil e no mundo. Como precursor de sua síntese 
utiliza-se o ácido salicílico (AS) que também é produzido através de sua degradação. A metodologia 
oficial da Farmacopéia Americana (USP) preconiza a determinação destes fármacos por cromatografia 
líquida de alta eficiência (CLAE) com detecção por ultravioleta, mas este método não possui boa 
sensibilidade (S
AAS
=0,12 mAbs/(µg/mL) e S
AS
=0,48 mAbs/(µg/mL)) e resolução (Rs =1,61). O objetivo 
deste trabalho, visando a melhor adequação do sistema cromatográfico em relação à metodologia 
oficial, foi o desenvolvimento e otimização de um novo método por cromatografia em fase líquida para 
determinar os teores tanto do ácido acetilsalicílico quanto do salicílico em comprimidos. Os parâmetros 
da adequação do sistema cromatográfico para o AAS e para o AS foram satisfatórios. A seletividade foi 
verificada por comparações dos espectros de absorção no ultravioleta (UV) antes, durante e depois do 
tempo de retenção da substância. A faixa linear de trabalho para o AAS foi de 0,21 a 0,39 mg/mL e a 
do AS foi de 6,3 a 11,7 µg/mL. Os coeficientes de correlação (r) das curvas analíticas do AAS e do AS 
foram de 0,9995 e 0,9988, respectivamente e os limites de detecção e quantificação para o AS foram 
0,23 e 0,69 μg/mL. A sensibilidade (S
AAS
=1,88 mAbs/(µg/mL) e S
AS
=1,84 mAbs/(µg/mL)) e a resolução 
(Rs=5,06) atestam a melhoria em relação ao método descrito na USP.
Unitermos: Cromatografia líquida de alta eficiência. Ácido acetilsalicílico/determinação em comprimidos. 
Ácido salicílico/determinação em comprimidos. Comprimidos/análise quantitativa.
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INTRODUCTION
Acetylsalicylic acid (Figure 1a), also known as 
aspirin, is the most popular drug worldwide. Every year, 
50,000,000,000 (50 billion) tablets of aspirin are sold world-
wide, and this does not include other forms of acetylsalicylic 
acid commonly found in the market, such as other aspirin 
preparations or associated with other components, such as 
caffeine or vitamin C. Salicylic acid (Figure 1b), a precursor 
and also a degradation product of aspirin, is a bifunctional 
molecule; and can present two types of esterification. In the 
presence of acetic anhydride, aspirin is formed, whereas 
in the presence of a methanol excess, the obtained product 
is methyl salicylate (Wintergreen Oil) (Akre et al., 2001). 
The method used by the United States Pharmaco-
poeia for simultaneous dosing of acetylsalicylic acid and 
salicylic acid in tablets is that of high performance liquid 
chromatography (USP 31, 2008). The experimental evalu-
ation of this method showed that the parameters for system 
adequacy (mainly resolution and enlargement factor) did 
not result in a reliable analysis. This chromatographic 
system also has a very low sensitivity (INMETRO, 2007), 
which is undesirable in any quantitative analytical method. 
Despite several adjustments developed in the mobile phase 
and the use of several columns of different dimensions, 
formats and particle diameter, an improvement in the 
obtained results has not been achieved.
In the development of this new analytical method, the 
fact that acetylsalicylic and salicylic acids are weak acids, 
whose ionization constants (pKa) are 3.5 and 3.0; respecti-
vely was taken into consideration. Thus, a better methodolo-
gy to analyze these acids is reversed phase chromatography 
with ionic suppression of species in solution, through pH 
control, and this was applied in the present study.
MATERIAL AND METHODS
Reagents
All the solutions were made utilizing ultrapure water 
of Milli-Q system (Millipore). The following reagents 
were obtained from Merck (Germany): grade HPLC ace-
tonitrile and analytical grade trifluoroacetic acid.
 Standards utilized were acetylsalicylic acid (Refe-
rence Chemical Substance of Brazilian Pharmacopoeia) 
with purity of 100.0% and salicylic acid (Standard of 
United States Pharmacopoeia) with purity of 99.4%.
Equipment
The following equipment was used for this study: 
Shimadzu liquid phase chromatograph, model SPD-
M10A, with diode arrangement type photometric detector 
in the ultraviolet-visible range, and Waters liquid phase 
chromatograph (model 2487), with photometric detector 
in the ultraviolet-visible range. The columns used were 
the Waters reversed phase Novopack, in silica coated with 
octadecylsilano (C18, 4 µm, 150 x 3.9 mm d.i.), and the 
Merck reversed phase Lichrospher, in silica coated with 
octadecylsilano (C18, 5 µm, 125 x 4 mm d.i.).
Analytical conditions
Table I presents analytical conditions accepted by 
United States Pharmacopoeia and the method developed 
in this study.
Study of degradation kinetic of acetylsalicylic acid
The degradation kinetic of acetylsalicylic acid was 
followed by the deacetylation reaction and, consequently, 
by the salicylic acid formation. A freshly prepared (ave-
rage preparation time of 25 minutes) solution of acetylsa-
licylic acid (0.302 mg/mL) was analyzed 30 consecutive 
times, and the salicylic acid tenor was determined in every 
chromatogram under the same analytical conditions using 
the newly developed method (Table I), in comparison to a 
standard-solution of salicylic acid 9.0613 mg/mL. 
Merit parameters evaluation
The molecular absorption spectra, in the ultraviolet 
range, of the acetylsalicylic and salicylic acids peaks were 
obtained in seven levels of the standard addition curve. 
Spectral comparisons before, during and after the subs-
tance characteristic retention time were done to evaluate 
the selectivity. The work linear range was defined as esta-
blished in the Guide of Validation of Analytical Methods 
by the National Health Surveillance Agency [Agência Na-
cional de Vigilância Sanitária (ANVISA, 2003)]. The first 
step of the procedure to evaluate the linearity of analytical 
response for the analyzed substances was done using the 
FIGURE 1 - Structural representations of acetylsalicylic acid 
(1a) and salicylic acid (1b).
Development of a new analytical method for determination of acetylsalicylic and salicylic acids 725
following experimental outline: i) determination of the 
concentration range of interest, considering the method 
application. The expected concentrations in the samples 
were chosen in a way to be close to middle range; ii) pre-
paration of an analytical curve using standard-solutions 
in seven concentration levels, equally spaced, prepared in 
triplicate, independent of every level; and iii) random in-
jection of solutions. Data analysis was done with ordinary 
minimum squares (Souza, Junqueira, 2005). The detection 
(DL) and quantification (QL) limits for the salicylic acid 
were evaluated by the signal/noise proportion, which is 
applicable to instrumental methods presenting basal noise 
(ANVISA, 2003).
 
RESULTS AND DISCUSSION
In accordance with USP 31 methodology (Table I), 
separate injections of 5 µL of acetylsalicylic and salicylic 
acids standard solutions were done. After determining the 
retention time of every compound, a solution containing 
both analyzed substances was injected, in order to evaluate 
the separation quality. However, the obtained resolution 
(Rs=1.61) was not in accordance with the minimal value 
stated by the FDA or USP 31 of at least two, as the enlar-
gement factor for the acetylsalicylic acid was above the 
maximum allowed (< 2). This system was also shown 
to give low sensitivity [S
AAS
=0.12 mAbs/(µg/mL) and 
S
AS
=0.48 mAbs/(µg/mL)]. 
The same standards have been analyzed utilizing 
the new methodology in this present study (Table I). The 
parameters of system adequacy, according chromatogram 
of Figure 2, are presented in Table II (average and varia-
tion coefficient of six replicates). The resolution obtained 
(Rs=5.06) demonstrates the improvement in the chro-
matographic separation ability as well as the sensitivity 
quality, which was 15.7 times superior for acetylsalicylic 
acid [S
AAS
=1.88 mAbs/(µg/mL)] and 3.8 times superior for 
salicylic acid [S
AS
=1.84 mAbs/(µg/mL)], in comparison to 
the method described in the USP. The tail factors lower than 
2 demonstrate the peak symmetry. The retention factors 
are within the range of 1 to 10, demonstrating the adequate 
eluent strength of the mobile phase. The number of plates 
is above the recommended value of 2000. The repeatability 
is satisfactory, being below the required value of 2% (USP 
31, 2008).
TABLE I - Analytical conditions of the literature method (USP) and the analytical method developed in this study, with samples 
injected in Waters and Shimadzu chromatographs
Analytical conditions Method of USP 31 Developed method
Column C18 (5µm; 250 x 4.6 mm d.i.) C18 (4 µm, 150 x 3.9 mm d.i.) 
(Waters) Novapack
Mobile phase and diluent Sodium 1-heptanesulfonate,  
water and acetonitrile  
(2 g : 850 mL : 150 mL) (pH 3.4)
acetonitrile : aqueous solution of 
trifluoroacetic acid, 0.05% (30:70)
Output 2.0 mL/min 1.0 mL/min
Detection 280 nm 230 nm
Temperature 30 ºC 30 ºC
Standard volume 10 µL 5 µL
Standard concentration 451.8 µg/mL of acetylsalicylic acid 
and 13.5 μg/mL of salicylic acid 
301.8 µg/mL of acetylsalicylic acid 
and 9.51 µg/mL of salicylic acid
TABLE II - Resolution, enlargement factor, retention factor, plate 
number and repeatability of peak areas of acetylsalicylic and 
salicylic acids with their respective coefficients of variation (cv)
Chromatographic 
parameter
Acetylsalicylic acid Salicylic acid
Resolution - 5.06 (cv 0.8%)
Enlargement factor 1.20 (cv 1.5%) 1.26 (cv 2.0%)
Retention factor 1.61 (cv 0.2%) 2.72 (cv 0.4%)
Plate number 3080 (cv 0.5%) 4177 (cv 1.2%)
Area repeatability DPR* = 0.3%  DPR = 0.2%
*RSD = Relative Standard Deviation
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The study of acetylsalicylic acid stability was 
developed through the analysis of a standard solution of 
0.302 mg/mL, during a period of 180 minutes, by liquid 
chromatography with detection in ultraviolet range, 
being verified as a linear trend in formation of salicylic 
acid, tenor (%)=0.0005t + 0.0302, R2=0.9935 (Figure 3). 
This result implies that, in order to assure the reliability 
of analytical results in samples that have a salicylic acid 
tenor which is very close to the tolerated limit (3.0%), 
the sample should be injected immediately after its 
preparation. According to the linear regression equation 
of the trend to formation of salicylic acid, it is possible 
to verify that after twenty five minutes (the preparation 
time of sample), an increase of 0.043% in the limit of 
free salicylic acid occurred.
FIGURE 2 - Chromatograms of acetylsalicylic (0.505 mg/mL) and salicylic acids (0.511 mg/mL), injected in the Shimadzu 
chromatograph with DAD*. AAS – retention time: 2.36 min; area: 8998285; plate number: 3191; enlargement factor: 1.21; 
retention factor: 1.62. AS – retention time: 3.35 min; area: 12441463; plate number: 4341; resolution: 5.36; enlargement factor: 
1.44; retention factor: 2.72.
*DAD = Diode Array Detector
FIGURE 3 - Curve of the kinetic of salicylic acid formation from a standard solution of acetylsalicylic acid (0.302 mg/mL). 
Pureness and selectivity of the peaks of acetyl-
salicylic and salicylic acids was confirmed through the 
comparison of spectra of molecular absorption in the 
ultraviolet range of the substance, against the spectra of 
molecular absorption in the ultraviolet of the respective 
standards of acetylsalicylic and salicylic acids.
The linearity of analytical curves of acetylsalicylic 
acid [area = 107 (mg/mL) - 48512, r=0.9995] and of sa-
licylic acid [area=12663 (μg/mL) + 1035, r=0.9988] in 
the studied concentrations range was confirmed and the 
residue graphics indicated homoscedastic behavior.
The detection and quantification limits determi-
ned from the analytical curve of salicylic acid were 
0.23 μg/mL and 0.69 μg/mL, respectively.
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CONCLUSIONS
The four adequacy parameters of the chromatogra-
phic system for AAS (enlargement factor 1.20; retention 
factor 1.61; plate number 2485 and relative standard 
deviation 0.3%) and AS (resolution 5.06; enlargement 
factor 1.26; retention factor 2.72; plate number 4177 and 
relative standard deviation 0.2%) were satisfactory. The 
selectivity was verified by comparing absorption spectra 
in UV before, during and after the characteristic time of 
retention for the substance. The work linear range for AAS 
was from 0.21 to 0.39 mg/mL and that for AS was from 
6.3 to 11.7 µg/mL. The correlation coefficients (r) of the 
analytical curves of AAS and AS were 0.9995 and 0.9988, 
respectively; and the detection and quantification limits for 
AS were 0.23 and 0.69 μg/mL, respectively. The proposed 
method can thus be employed for the quantitative deter-
mination of acetylsalicylic and salicylic acids in tablets, 
having proved rapid, simple, selective and sensitive.
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